Hydrix Limited · ASX:HYD
Hydrix — Australian Microcap Investment Conference 2022
17 slides from Hydrix's conference presentation, Oct 18, 2022
Slide 1: Realising our vision to improve a billion lives
hudrix” Realising our vision to improve a billion lives through disruptive medical devices
Slide 2: Our company
th company Our vision is to imp a billion li Jr arich2 Transform disruptive medical technologies into commercial products for global customers Identify and make minority Venture investments where Hydrix is development partner Merging cardiovascular technology innovation with Cardiac field expertise
Slide 3: For personal use only
For personal use only • • • • • • • • • • • • • • • •
Slide 4: For personal use only
For personal use only • • • • • • • • • •
Slide 5: For personal use only
For personal use only • • • • • • • • • • • • • • • • •
Slide 6: For personal use only
For personal use only • • • • • • • • • • • • • • • • •
Slide 7: Medical: The GUARDIAN regulatory & insurance reimbursement market development
Hydrix Medical: The GUARDIAN Regulatory & insurance reimbursement market development Hydrix is actively working on regulatory approvals and reimbursement processes across multiple jurisdictions, and other market development activities to commercialise The Guardian Country* / Agency Appl. Date Status
Slide 8: For personal use only
For personal use only • • • • • • • • o o o o o o o o o o
Slide 9: Highly experienced and credentialled board
Hydrix Limited Highly experienced and credentialled board Coote Executive Chairman Gavin has exte and board leadership experience, gained in the USA and Australia, working a companies with revenues of 4p to $1 billion across diverse ive executive industries, It includes years with PricewaterhouseCoo
Slide 10: Corporate snapshot
Hydrix Limited Corporate snapshot Major Shareholders Shares (m) % Capital Structure (as of 14 October 2022) John W. King Nominees 273 nS Ticker HYD Paul Lewis (Invia Custodian) 149 64 Share Price $0.06 Roger Allen & related entities 10.4 45 Shares on Issue (m) 231.0 Pusen Medical Technology Australi
Slide 11: Building momentum
Creating positive outcomes in global healthcare FOr Reyna! use only Building momentum Hydrix Services: Strong year-on-year growth, profitability ahead Hydrix Ventures: Major inflection points anticipated in CY23 Hydrix Medical: The GUARDIAN: catalyst for product revenue growth Hydrix Limited: Capita
Slide 12: Appendix
ppendix A Ajuo asn jeuosied 10)
Slide 13: Medical: The GUARDIAN APAC region market potential
Hydrix Medical: The GUARDIAN APAC region market potential SS (“GUARDIAN® market Potential Market Size (illustration only) Annua Volume (units) (penetration leverages “s-decades of “pacemaker surgery Australia Ss know-how and existing catheter Singapore ©. "laboratory New Zealand 51 18,000 360 900 $3
Slide 14: Senior Leadership
Hydrix Senior Leadership Vickie Edwards Director Sales & Operations Hydrix Medical Vickie has more than 25 years of health technology industry expertise. cardiothoracic clinical experience and a deep commercial capability and understandir successfully bring net interventional cardiac devices to mark
Slide 15: Senior Leadership Hydrix Services
Hydrix Senior Leadership Hydrix Services Michael Trieu General Manager Hydrix Services Michael is an R&D innovation leader with 20 years of hands-on system innovation research, design development and delivery experience in the field of military underwater sonar, active implantable medical devices, m
Slide 16: Disclaimer
Disclaimer This presentation has been prepared by Hydrix Limited (the “Company’ or “Hydrix’). This presentation is being provided to investors for the sole purpose of providing preliminary background financial and other information to enable recipients to review the business activities of the Compan
Slide 17: For personal use only
hudrix™ Ajuo asn feuosied 10) m www.hydrix.co
Hydrix — Australian Microcap Investment Conference 2022 on 6ix